PREPRINT (not peer reviewed)

Age and cannabis co-use are associated with differences in experience and perceived benefits of psilocybin: a retrospective study

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: PsyArXiv
Date: 2025-12-10
Source: PsyArXiv
DOI: Unavailable
PubMed: Unavailable

Authors

Jake Hooper Sarah Williams Raeghan Mueller Kent Hutchison

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Addiction Mechanism of Action Aging Mystical Experience Older Adults Other

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult VolunteersClinicalTrials.gov · 2023-05-19 Multivariate Neural and Physiological Correlates of Psychedelic Sub-states: a Within-subjects, Healthy Volunteer Study With Experience-samplingClinicalTrials.gov · 2026-06-05 The Role of the Subjective Experience in Supporting Positive Effects Following Psilocybin: a Randomized, Controlled Clinical Trial Using Risperidone in Healthy AdultsClinicalTrials.gov · 2026-06-02 The Effects of Psilocybin on Shared Experience in Film ProcessingClinicalTrials.gov · 2024-09-27 Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects ("MELO"): A Blinded, Placebo-Controlled, Dose-Finding StudyClinicalTrials.gov · 2023-03-20 Visual Surround Suppression and Perceptual Expectation Under PsilocybinClinicalTrials.gov · 2025-06-27 Safety for Home Administration of Microdose Psilocybin UseClinicalTrials.gov · 2026-08-14 Activating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of PsilocybinClinicalTrials.gov · 2026-07-29